Sara Keihanian

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Background: Esophageal Crohn's disease is reported as a rare manifestation, although its prevalence may be underestimated because upper endoscopies are not routinely performed in asymptomatic adults. Tofacitinib, an oral janus kinase inhibitor, is a new biologic that has shown promise in the treatment of ulcerative colitis and may be effective in the(More)
  • 1